The accompanying notes are an integral part of
these unaudited condensed financial statements.
The accompanying notes are an integral part of
these unaudited condensed financial statements.
The accompanying notes are an integral part of
these unaudited condensed financial statements.
The accompanying notes are an integral part of
these unaudited condensed financial statements.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2021
(Unaudited)
Note 1 — Description of
Organization and Business Operations
FTAC Olympus Acquisition
Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on June 2, 2020. The Company
was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business
combination with one or more businesses or entities (the “Business Combination”).
The Company is not limited
to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth
company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
As of March 31, 2021, the
Company had not commenced any operations. All activity through March 31, 2021 relates to the Company’s formation, the initial public
offering (“Initial Public Offering”), which is described below, and, since its Initial Public Offering, identifying a target
company for a Business Combination and the potential acquisition, as more fully described in Note 6. The Company will not generate any
operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating
income in the form of interest income from the proceeds derived from the Initial Public Offering.
The registration statement
for the Company’s Initial Public Offering was declared effective on August 25, 2020. On August 28, 2020, the Company consummated
the Initial Public Offering of 75,000,000 units (the “Units” and, with respect to the Class A ordinary shares included
in the Units being offered, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $750,000,000 which is described
in Note 3.
Simultaneously with the closing
of the Initial Public Offering, the Company consummated the sale of 2,170,000 units (each, a “Placement Unit” and collectively,
the “Placement Units”) at a price of $10.00 per Placement Unit in a private placement to FTAC Olympus Sponsor, LLC, generating
gross proceeds of $21,700,000, which is described in Note 4. The managers of FTAC Olympus Sponsor, LLC are Betsy Z. Cohen and Ryan M.
Gilbert.
On September 23, 2020, the
underwriters partially exercised their over-allotment option, resulting in the sale of an additional 474,379 Units for total gross proceeds
of $4,743,760. A total of $4,743,760 was deposited into the Trust Account, bringing the aggregate proceeds held in the Trust Account to
$754,743,760.
Transaction costs charged
to equity amounted to $45,956,853, consisting of $15,000,000 of underwriting fees, $30,284,626 of deferred underwriting fees and $672,227
of other offering costs.
Following the Initial Public Offering, the exercise
of the over-allotment option and the sale of the Placement Units, a total of $754,743,760 ($10.00 per Unit) from the net proceeds of the
sale of the Units in the Initial Public Offering and the sale of the Placement Units was placed in a trust account (the “Trust Account”),
located in the United States and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16)
of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out
as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act of 1940, as amended
(the “Investment Company Act”), as determined by the Company, until the earlier of: (i) the completion of a Business
Combination; (ii) the redemption of any Public Shares properly tendered in connection with a shareholder vote to amend the Company’s
Amended and Restated Memorandum and Articles of Association (A) to modify the substance or timing of the Company’s obligation
to redeem 100% of its Public Shares if it does not complete a Business Combination by August 28, 2022 or (B) with respect to any
other provision relating to shareholders’ rights or pre-initial Business Combination activity and (iii) the distribution of
the Trust Account, as described below, except that interest earned on the Trust Account can be released to pay the Company’s tax
obligations, if the Company is unable to complete an initial Business Combination within the Combination Period or upon any earlier liquidation
of the Company.
The Company’s
management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale
of the Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business
Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete
one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account
(excluding the deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the agreement
to enter into the initial Business Combination. The Company will only complete a Business Combination if the post-transaction company
owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target
sufficient for it not to be required to register as an investment company under the Investment Company Act.
FTAC OLYMPUS ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2021
(Unaudited)
The Company will provide
holders of the outstanding Public Shares (the “public shareholders”) with the opportunity to redeem all or a portion of their
Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the
Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of
a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public shareholders will be
entitled to redeem their Public Shares for a pro rata portion of the amount then on deposit in the Trust Account (initially $10.00 per
Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay
its tax obligations). The per-share amount to be distributed to public shareholders who redeem their Public Shares will not be reduced
by the deferred underwriting commissions the Company will pay to the representatives on behalf of the underwriters (as discussed in Note
6). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.
The Company will proceed
with a Business Combination if the Company has net tangible assets of at least $5,000,001 either prior to or upon such consummation of
a Business Combination and, if the Company seeks shareholder approval, it receives an ordinary resolution under Cayman Islands law approving
a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting
of the Company. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or
other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association (the “Amended
and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities
and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If,
however, shareholder approval of the transaction is required by law, or the Company decides to obtain shareholder approval for business
or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not
pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a Business Combination, FTAC Olympus
Sponsor, LLC and FTAC Olympus Advisors, LLC (collectively, the “Sponsor”) and the Company’s officers and directors (the
“Insiders”) have agreed to vote their Founder Shares (as defined in Note 5), the Class A ordinary shares included in
the Placement Units (the “Placement Shares”) and any Public Shares held by them in favor of approving a Business Combination.
Additionally, each public shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed
transaction.
Notwithstanding the foregoing,
if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules,
the Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such
shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with
respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.
The Insiders have agreed
(a) to waive their redemption rights with respect to their Founder Shares, Placement Shares and Public Shares held by them in connection
with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles
of Association (i) to modify the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the
Company does not complete a Business Combination or (ii) with respect to the other provisions relating to shareholders’ rights
or pre-business combination activity, unless the Company provides its public shareholders with the opportunity to redeem their Class A
ordinary shares upon approval of any such amendment.
The Company will have until
August 28, 2022 to complete a Business Combination (the “Combination Period”). If the Company has not completed a Business
Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as
promptly as reasonably possible, but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable
in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest will be net of taxes payable,
and less up to $100,000 of interest to pay dissolution expenses) divided by the number of then issued and outstanding Public Shares, which
redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating
distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s
shareholders and board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Cayman Islands
law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating
distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination
within the Combination Period.
The Insiders have agreed
to waive their liquidation rights with respect to their Founder Shares and Placement Shares if the Company fails to complete a Business
Combination within the Combination Period. However, if the Insiders acquire Public Shares in or after the Initial Public Offering, such
Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination
within the Combination Period. The representatives of the underwriters have agreed to waive their rights to their deferred underwriting
commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination
Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund
the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining
available for distribution will be less than the Initial Public Offering price per Unit ($10.00).
FTAC OLYMPUS ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2021
(Unaudited)
In order to protect the amounts
held in the Trust Account, FTAC Olympus Sponsor, LLC has agreed to be liable to the Company if and to the extent any claims by a third
party (other than our independent auditors) for services rendered or products sold to the Company, or a prospective target business with
which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.00
per Public Share or (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust
Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes. This
liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the
Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against
certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover,
in the event that an executed waiver is deemed to be unenforceable against a third party, FTAC Olympus Sponsor, LLC will not be responsible
to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that FTAC Olympus Sponsor,
LLC will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than
our independent registered public accounting firm), prospective target businesses or other entities with which the Company does business,
execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Note 2 — Summary of Significant
Accounting Policies
Basis of Presentation
The accompanying unaudited
condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of
America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation
S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP
have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do
not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash
flows. In the opinion of management, the accompanying unaudited condensed interim financial statements include all adjustments, consisting
of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows
for the periods presented.
The accompanying unaudited
condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K/A for the year ended
December 31, 2020 as filed with the SEC on May 7, 2021, which contains the audited financial statements and notes thereto. The interim
results for the three months ended March 31, 2021 are not necessarily indicative of the results to be expected for the year ending December
31, 2021 or for any future interim periods.
Emerging Growth Company
The Company is an “emerging
growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of
2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable
to other public companies that are not emerging growth companies, including, but not limited to, not being required to comply with the
independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure
obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding
a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1)
of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until
private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class
of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS
Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period,
which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company,
as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company
nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential
differences in accounting standards used.
Use of Estimates
The preparation of condensed
financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts
of revenues and expenses during the reporting period.
Making estimates requires
management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation
or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate,
could change in the near term due to one or more future events. Accordingly, the actual results could differ significantly from those
estimates.
One of the more significant
accounting estimates included in these unaudited condensed financial statements is the determination of the fair value of the warrant
liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could
differ significantly from those estimates.
FTAC OLYMPUS ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2021
(Unaudited)
Cash and Cash Equivalents
The Company considers all
short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have
any cash equivalents as of March 31, 2021 and December 31, 2020.
Marketable Securities Held in Trust Account
At March 31, 2021 and December
31, 2020, the assets held in the Trust Account were held in money market funds which are invested primarily in U.S. Treasury Securities.
Warrant Liabilities
The Company accounts for
warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms
and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”)
480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”).
The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability
pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether
the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net
cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This
assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly
period end date while the warrants are outstanding.
For issued or modified warrants
that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in
capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants
are required to be recorded as a derivative liability at their initial fair value on the date of issuance, and each balance sheet date
thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations.
The fair value of the Public Warrants was initially measured using a binomial / lattice model with subsequent periods measured at the
trading price, whereas the Private Placement Warrants were initially and subsequently measured using the Black-Scholes Option Pricing
Model. (see Note 8). In accordance with ASC 825-10 “Financial Instruments”, offering costs attributable to the issuance of
the derivative warrant liabilities are recognized in the statement of operations as incurred.
Ordinary Shares Subject to Possible Redemption
The Company accounts for
its ordinary shares subject to possible redemption in accordance with the guidance in ASC 480 “Distinguishing Liabilities from Equity.”
Ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally
redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder
or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary
equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature
certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain
future events. Accordingly, at March 31, 2021 and December 31, 2020, ordinary shares subject to possible redemption are presented as temporary
equity, outside of the shareholders’ equity section of the Company’s condensed balance sheets.
Income Taxes
The Company accounts for
income taxes under ASC Topic 740, “Income Taxes,” which prescribes a recognition threshold and a measurement attribute for
the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits
to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s
management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and
penalties related to unrecognized tax benefits as income tax expense. As of March 31, 2021, there were no unrecognized tax benefits and
no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant
payments, accruals or material deviation from its position.
The Company is considered
to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes
or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero
for the period presented.
FTAC OLYMPUS ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2021
(Unaudited)
Net Income (Loss) Per Ordinary Share
The Company complies with
accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” Net income (loss) per share is computed
by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. The calculation of diluted
income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, (ii) the
partial exercise of the over-allotment option and (iii) the Placement Units since the exercise of the warrants are contingent upon the
occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable to purchase 25,881,458
shares of Class A ordinary shares in the aggregate.
The Company’s statement
of operations includes a presentation of loss per share for ordinary shares subject to possible redemption in a manner similar to the
two-class method of loss per share. Net income per ordinary share, basic and diluted, for Class A redeemable ordinary shares is calculated
by dividing the interest income earned on the Trust Account, by the weighted average number of Class A redeemable ordinary shares outstanding
since original issuance. Net loss per ordinary share, basic and diluted, for Class A and Class B non-redeemable ordinary shares is calculated
by dividing the net loss, adjusted for income attributable to Class A redeemable ordinary shares, by the weighted average number of Class
A and Class B non-redeemable ordinary shares outstanding for the period. Class A and Class B non-redeemable ordinary shares include the
Founder Shares and the Placement Shares as these shares do not have any redemption features and do not participate in the income earned
on the Trust Account.
The following table reflects
the calculation of basic and diluted net loss per ordinary share (in dollars, except per share amounts):
|
|
For the Three
Months Ended March 31,
2021
|
|
Redeemable Class A Ordinary Shares
|
|
|
|
Numerator: Earnings allocable to Redeemable Class A Ordinary Shares
|
|
|
|
Interest Income
|
|
$
|
18,612
|
|
Net Earnings
|
|
$
|
18,612
|
|
Denominator: Weighted Average Redeemable Class A Ordinary Shares
|
|
|
|
|
Redeemable Class A Ordinary Shares, Basic and Diluted
|
|
|
75,474,376
|
|
Earnings/Basic and Diluted Redeemable Class A Ordinary Shares
|
|
$
|
-
|
|
|
|
|
|
|
Non-Redeemable Class A and B Ordinary Shares
|
|
|
|
|
Numerator: Net Loss minus Redeemable Net Earnings
|
|
|
|
|
Net Loss
|
|
$
|
(9,048,908
|
)
|
Redeemable Net Earnings
|
|
$
|
(18,612
|
)
|
Non-Redeemable Net Loss
|
|
$
|
(9,067,520
|
)
|
Denominator: Weighted Average Non-Redeemable Class A and B Ordinary Shares
|
|
|
|
|
Non-Redeemable Class A and B Ordinary Shares, Basic and Diluted
|
|
|
21,581,094
|
|
Loss/Basic and Diluted Non-Redeemable Class A and B Ordinary Shares
|
|
$
|
(0.42
|
)
|
Note: As of March 31, 2021, basic and diluted shares are the same as
there are no non-redeemable securities that are dilutive to the Company’s ordinary shareholders.
The weighted average non-redeemable
ordinary shares for the three months ended March 31, 2021 includes the effect of 2,170,000 Placement Units, which were issued in conjunction
with the initial public offering on August 28, 2020.
Concentration of Credit Risk
Financial instruments that
potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times,
may exceed the Federal Depository Insurance Corporation limit of $250,000. The Company has not experienced losses on this account and
management believes the Company is not exposed to significant risks on such account.
FTAC OLYMPUS ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2021
(Unaudited)
Fair Value of Financial Instruments
The fair value of the Company’s
assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates
the carrying amounts represented in the Company’s condensed balance sheet, primarily due to their short-term nature. As of March
31, 2021, the carrying values of cash, accounts payable and accrued expenses approximate their fair values due to the short-term nature
of the instruments. The Company’s portfolio of marketable securities held in the Trust Account is comprised of investments in U.S.
Treasury securities with an original maturity of 185 days or less. The fair value for trading securities is determined using quoted market
prices in active markets.
Recent Accounting Standards
In August 2020, the FASB
issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts
in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU
2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP.
The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception,
and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on January 1, 2021. Adoption
of the ASU did not impact the Company’s financial position, results of operations or cash flows.
Management does not believe
that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the Company’s
unaudited condensed financial statements.
Note 3 — Initial Public
Offering
Pursuant to the Initial Public
Offering, the Company sold 75,474,376 Units, which includes the partial exercise by the underwriters of their over-allotment option on
September 23, 2020 in the amount of 474,376 Units, at a price of $10.00 per Unit. Each Unit consists of one Class A ordinary share
and one-third of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one
Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 7).
Note 4 — Private Placement
Simultaneously with the closing
of the Initial Public Offering, FTAC Olympus Sponsor, LLC purchased an aggregate of 2,170,000 Placement Units at a price of $10.00 per
Placement Unit, for an aggregate purchase price of $21,700,000. Each Placement Unit consists of one Placement Share and one-third of one
redeemable warrant (“Placement Warrant”). Each whole Placement Warrant is exercisable to purchase one Class A ordinary
share at a price of $11.50 per share. The proceeds from the Placement Units were added to the proceeds from the Initial Public Offering
held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the
sale of the Placement Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law),
and the Placement Units and all underlying securities will be worthless.
Note 5 — Related Party
Transactions
Founder Shares
In June 2020, the Sponsor
purchased 8,845,000 Class B ordinary shares (the “Founder Shares”) for an aggregate price of $25,000. In August 2020,
the Company effected a share capitalization pursuant to which the Company issued an additional 13,260,000 ordinary shares, resulting in
a total of 22,105,000 Founder Shares issued and outstanding. The Founder Shares included up to 2,812,500 shares subject to forfeiture
to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the number of Founder Shares
will represent 20% of the aggregate Founder Shares, Placement Shares and issued and outstanding Public Shares after the Initial Public
Offering. On September 23, 2020, in connection with the underwriters’ partial exercise of the over-allotment option and the forfeiture
of the remaining over-allotment option, 2,693,906 Founder Shares were forfeited and 118,594 Founder Shares are no longer subject to forfeiture.
As a result, at March 31, 2021, there were 19,411,094 Founder Shares outstanding.
The Insiders have agreed,
subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares (i) with respect to 25% of such shares,
until consummation of a Business Combination, (ii) with respect to 25% of such shares, when the closing price of the Class A
ordinary shares exceeds $12.00 for any 20 trading days within a 30-trading day period following the consummation of a Business Combination,
(iii) with respect to 25% of such shares, when the closing price of the Class A ordinary shares exceeds $13.50 for any
20 trading days within a 30-trading day period following the consummation of a Business Combination, and (iv) with respect to 25%
of such shares, when the closing price of the Class A ordinary shares exceeds $17.00 for any 20 trading days within a 30-trading
day period following the consummation of a Business Combination or earlier, in any case, if, following a Business Combination, the Company
completes a liquidation, merger, share exchange or other similar transaction that results in all of the Company’s shareholders having
the right to exchange their ordinary shares for cash, securities or other property.
FTAC OLYMPUS ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2021
(Unaudited)
Promissory Note – Related Party
On June 17, 2020, FTAC Olympus
Sponsor, LLC agreed to loan the Company an aggregate of up to $500,000 to cover expenses related to the Initial Public Offering pursuant
to a promissory note (the “Promissory Note”). The Promissory Note was non-interest bearing and payable on the earlier of December
31, 2020 or the completion of the Initial Public Offering. Outstanding balances of $300,000 under the Promissory Note were repaid upon
the closing of the Initial Public Offering on August 28, 2020. On September 1, 2020, the Company repaid the $5,000 outstanding balance
under the Promissory Note.
Administrative Support Agreement
The Company entered into
an agreement, commencing on August 25, 2020 through the earlier of the Company’s consummation of a Business Combination or its liquidation,
to pay an affiliate of the Sponsor a total of $25,000 per month for office space, administrative and shared personnel support services.
For the three months ended March 31, 2021, the Company incurred and paid $75,000 in fees for these services.
Related Party Loans
In order to finance transaction
costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers
and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the
Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released
to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that
a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital
Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms
of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working
Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $1,500,000
of such Working Capital Loans may be convertible into units of the post-Business Combination entity at a price of $10.00 per unit.
The units would be identical to the Placement Units. As of March 31, 2021 and December 31, 2020, the Company had no outstanding borrowings
under the Working Capital Loans.
Note 6 — Commitments and
Contingencies
Risks and Uncertainties
Management continues to evaluate
the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect
on the Company’s financial position, results of its operations and/or a business combination, the specific impact is not readily
determinable as of the date of these financial statements. The unaudited condensed financial statements do not include any adjustments
that might result from the outcome of this uncertainty.
Registration Rights
Pursuant to a registration
rights agreement entered into on August 25, 2020, the holders of the Founder Shares, Placement Units (including securities contained therein)
and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise
of the Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) are entitled to registration rights
to require the Company to register a sale of any securities held by them (in the case of the Founder Shares, only after conversion to
Class A ordinary shares). The holders of these securities will be entitled to make up to three demands, excluding short form demands,
that the Company register such securities for sale under the Securities Act. In addition, these holders will have “piggy-back”
registration rights to include such securities in other registration statements filed by the Company and rights to require the Company
to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement
provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination
of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration
statements.
Underwriting Agreement
The underwriters were paid
a cash underwriting discount of 2.0% of the gross proceeds of the Initial Public Offering, or $15,000,000 in the aggregate. In addition,
the representatives of the underwriters are entitled to a deferred fee of $30,284,626. The deferred fee will become payable to the representatives
from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms
of the underwriting agreement.
FTAC OLYMPUS ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2021
(Unaudited)
Reorganizing Agreement
On February 3, 2021, the Company entered into an Agreement and Plan
of Reorganization (the “Reorganization Agreement”) by and among the Company, New Starship Parent Inc., a Delaware corporation
(“New Starship”), Starship Merger Sub I Inc., a Delaware corporation and a direct, wholly-owned subsidiary of New Starship
(“First Merger Sub”), Starship Merger Sub II Inc., a Delaware corporation and a direct, wholly-owned subsidiary of New Starship
(“Second Merger Sub” and, together with First Merger Sub, the “Merger Subs”) and Payoneer Inc., a Delaware corporation
(“Payoneer”, and together with us, New Starship and the Merger Subs, the “Parties”).
Pursuant to the Reorganization Agreement, the
Parties have agreed that, on the terms and subject to the conditions set forth therein, at the Closing (as defined in the Reorganization
Agreement), (i) First Merger Sub will merge with and into the Company (the “FTOC Merger”), with the Company surviving as a
direct wholly owned subsidiary of New Starship and (ii) immediately thereafter, Second Merger Sub will merge with and into Payoneer (the
“Payoneer Merger” and, together with the FTOC Merger, the “Mergers”) with Payoneer surviving as a direct wholly
owned subsidiary of New Starship (the transactions contemplated by the Reorganization Agreement, the “Reorganization”).
The Reorganization Agreement contains customary
representations, warranties and covenants by the parties thereto and the closing is subject to certain conditions as further described
in the Reorganization Agreement.
Note 7 — Shareholders’
Equity
Preference Shares —
The Company is authorized to issue 5,000,000 preference shares with a par value of $0.0001 per share with such designations, voting and
other rights and preferences as may be determined from time to time by the Company’s board of directors. At March 31, 2021 and December
31, 2020, there were no preference shares issued or outstanding.
Class A Ordinary
shares — The Company is authorized to issue 500,000,000 Class A ordinary shares with a par value of $0.0001 per
share. Holders of Class A ordinary shares are entitled to one vote for each share. At March 31, 2021 and December 31, 2020, there
were 10,981,497 and 10,076,606 Class A ordinary shares respectively issued and outstanding, excluding 66,662,879 and 67,567,770 Class A
ordinary shares subject to possible redemption.
Class B Ordinary
shares — The Company is authorized to issue 50,000,000 Class B ordinary shares with a par value of $0.0001 per
share. Holders of Class B ordinary shares are entitled to one vote for each share. At March 31, 2021 and December 31, 2020, there
were 19,411,094 Class B ordinary shares issued and outstanding.
Holders of Class B ordinary
shares will vote on the appointment of directors prior to the consummation of a Business Combination. Holders of Class A ordinary
shares and Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of shareholders
except as required by law.
The Class B ordinary
shares will automatically convert into Class A ordinary shares at the time of a Business Combination on a one-for-one basis, subject
to adjustment. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess
of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which Class B
ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding
Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of
Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as-converted
basis, 20% of the sum of all ordinary shares outstanding upon the completion of the Initial Public Offering and the private placement
plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with a Business Combination (excluding
any shares or equity-linked securities issued, or to be issued, to any seller in a Business Combination, any private placement-equivalent
shares and warrants underlying units issued to the Sponsor or its affiliates upon conversion of loans made to the Company).
Note 8 — Warrants
Warrants —
Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units
and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion
of a Business Combination or (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years
after the completion of a Business Combination or earlier upon redemption or liquidation. At March 31, 2021 and December 31, 2020, there
were 25,881,458 warrants outstanding (25,158,125 Public Warrants and 723,333 Placement Warrants).
The Company will not be obligated
to deliver any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise
unless a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then
effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration.
No warrant will be exercisable and the Company will not be obligated to issue any Class A ordinary shares upon exercise of a warrant
unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising
holder, or an exemption is available.
FTAC OLYMPUS ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2021
(Unaudited)
The Company has agreed that
as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, the Company will use
its best efforts to file, and within 60 business days following a Business Combination to have declared effective, a registration statement
covering the Class A ordinary shares issuable upon exercise of the warrants. The Company will use its best efforts to cause the same
to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until
the expiration of the warrants in accordance with the provisions of the warrant agreement. Notwithstanding the foregoing, if a registration
statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective within a specified period
following the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement
and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless
basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If
that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.
Redemption of warrants
when the price per Class A ordinary share equals or exceeds $18.00. Once the Public Warrants become exercisable, the Company
may redeem the Public Warrants:
|
●
|
in whole and not in part;
|
|
●
|
at a price of $0.01 per warrant;
|
|
●
|
upon not less than 30 days’ prior written notice of redemption to each warrant holder; and
|
|
●
|
if, and only if, the closing price of the Company’s Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the notice of redemption is given to the warrant holders.
|
If and when the warrants
become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying
securities for sale under all applicable state securities laws.
Redemption of warrants
for Class A Ordinary Shares when the price per Class A ordinary share equals or exceeds $10.00. Commencing ninety days after
the warrants become exercisable, the Company may redeem the Public Warrants:
|
●
|
in whole and not in part;
|
|
●
|
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the “fair market value” of the Class A ordinary shares;
|
|
●
|
if, and only if, the closing price of the Class A ordinary shares equals or exceeds $10.00 per Public Share (as adjusted for share sub-divisions, share dividends, reorganizations, reclassifications, recapitalizations and the like) on the trading day before the Company sends the notice of redemption to the warrant holders;
|
|
●
|
if, and only if, the Placement Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above; and
|
|
●
|
if, and only if, there is an effective registration statement covering the issuance of Class A ordinary shares issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the 30-day period after written notice of redemption is given.
|
In addition, if (x) the
Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the
closing of a Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price
or effective issue price to be determined in good faith by the Company and in the case of any such issuance to the Insiders or their affiliates,
without taking into account any Founder Shares held by the Insiders or such affiliates, as applicable, prior to such issuance) (the “Newly
Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 50% of the total equity proceeds,
and interest thereon, available for the funding of a Business Combination on the date of the completion of a Business Combination (net
of redemptions), and (z) the volume-weighted average trading price of the Class A ordinary shares during the 20 trading day
period starting on the trading day prior to the day on which the Company completes a Business Combination (such price, the “Market
Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115%
of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices will be adjusted
(to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.
The Placement Warrants are
identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Placement Warrants and the
Class A ordinary shares issuable upon the exercise of the Placement Warrants will not be transferable, assignable or salable until
30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants
will be exercisable on a cashless basis and, subject to limited exceptions, be non-redeemable so long as they are held by the initial
purchasers or their permitted transferees. If the Placement Warrants are held by someone other than the initial purchasers or their permitted
transferees, the Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public
Warrants.
FTAC OLYMPUS ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2021
(Unaudited)
Note 9 — Fair Value Measurements
At March 31, 2021, assets
held in the Trust Account were comprised of $754,787,779 in money market funds which are invested primarily in U.S. Treasury Securities.
The fair value of the Company’s
financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with
the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants
at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the
use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions
about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities
based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
Level 1:
|
Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
|
Level 2:
|
Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
|
Level 3:
|
Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
|
The following table presents
information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at March 31, 2021 and
December 31, 2020 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
Description
|
|
Level
|
|
|
March 31,
2021
|
|
|
December 31,
2020
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
Marketable securities held in Trust Account – U.S. Treasury Securities Money Market Fund
|
|
|
1
|
|
|
$
|
754,787,779
|
|
|
$
|
754,769,167
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant liabilities – Public Warrants
|
|
|
1
|
|
|
$
|
53,586,806
|
|
|
$
|
47,800,438
|
|
Warrant liabilities – Placement Warrants
|
|
|
3
|
|
|
$
|
1,540,699
|
|
|
$
|
1,374,333
|
|
The Warrants were accounted
for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on our balance sheet. The warrant liabilities
are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of
warrant liabilities in the consolidated statement of operations.
The Placement Warrants
were initially valued using a binomial /lattice model. The Placement Warrants are considered to be a Level 3 fair value measurements
due to the use of unobservable inputs. The binomial / lattice model’s primary unobservable input utilized in determining the
fair value of the Placement Warrants is the expected volatility of the ordinary shares. The expected volatility as of the Initial
Public Offering date was derived from the historical volatilities of comparable companies for a potential merger target as
represented by firms in the Russell 3000 Index. For periods subsequent to the detachment of the warrants from the Units, including
December 31, 2020 and March 31, 2021, the closing price of the Public Warrants was used to estimate the fair value of the Placement
Warrants as of each relevant date. A binomial / lattice model was used in estimating the fair value of the Public Warrants for
periods where no observable traded price was available, using the same expected volatility as was used in measuring the fair value
of the Placement Warrants. For periods subsequent to the detachment of the warrants from the Units, including December 31, 2020 and
March 31, 2021, the closing price of the Public Warrants was used as the fair value as of each relevant date.
FTAC OLYMPUS ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2021
(Unaudited)
The following table presents
the changes in the fair value of warrant liabilities:
|
|
Private Placement
|
|
|
Public
|
|
|
Warrant Liabilities
|
|
Fair value as of December 31, 2020
|
|
$
|
1,374,333
|
|
|
$
|
47,800,438
|
|
|
$
|
49,174,771
|
|
Change in valuation inputs or other assumptions
|
|
|
166,366
|
|
|
|
5,786,368
|
|
|
|
5,952,734
|
|
Fair value as of March 31, 2021
|
|
$
|
1,540,699
|
|
|
$
|
53,586,806
|
|
|
$
|
55,127,505
|
|
Transfers to/from Levels
1, 2 and 3 are recognized at the end of the reporting period. There were no transfers between levels for the period from December 31,
2020 through March 31, 2021.
Note 10 — Subsequent Events
The Company evaluated subsequent
events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were
issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in
the unaudited condensed financial statements.